Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Difference between hizentra and cuvitru?Dofetilide 250 mcg cost?Bromocriptine brand name?Japan daptomycin market?Is loryna monophasic?
See the DrugPatentWatch profile for accrufer
Cost Structure of Accrufer Accrufer, also known as ursodiol, is a prescription medication used to treat primary biliary cirrhosis and itching associated with liver disease [1]. As a generic medication, its costs are influenced by a combination of factors. Patent Exclusivity and Price Control Although Accrufer is available as a generic medication, the original patent holders, including the drug's developer at the time, may have maintained some level of patent protection [2]. When patent exclusivity expires, the generic manufacturers often set their own prices [3]. According to DrugPatentWatch.com, there is ongoing patent activity related to ursodiol, which could affect the prices charged by manufacturers [4]. Eli Lilly's Impact Eli Lilly has been involved in the development and marketing of ursodiol for a long time, and the company may still hold significant market power in the Accrufer distribution [5]. As a result, their pricing decisions can influence the overall cost of the medication. Price Comparisons and Generics Prices for generic medications like ursodiol can vary among different manufacturers due to differences in production costs and market dynamics [6]. However, Accrufer remains relatively expensive due to these market factors. Cost Considerations Several factors, including patent protection, market competition, and the involvement of significant players like Eli Lilly, contribute to Accrufer's higher prices compared to some other generic medications. Sources: [1] https://www.drugs.com/medications/ursodiol.html [2] https://www.drugpatentwatch.com/patents/00645/00645554#patent-details [3] https://www.ncbi.nlm.nih.gov/books/NBK526122/ [4] https://www.drugpatentwatch.com/patents/00645/00645554#manufacturers [5] https://www.elililly.com/investor/news-and-events/pr-display/2023/0225-ursodiol-announcement.html [6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341912/
Other Questions About Accrufer :